Insider trades

Goff Brian, CEO of Agios Pharmaceuticals AGIO, has filed 0 purchases and 19 sales on the open market. Over the past 12 months that comes to a net sale of $1.7M. The latest trade was on 06/18.

Goff Brian

CEO
First filing
23/03/03
Trades
73 trades
Buys / sales
0 / 19
12-month net buying
−$1.7M
Last trade
06/18

Trading activity

Transactions

Trade type
AGIO
Open-market sale10b5-1 plan04/0204/0619,068 sh2 trades$34.71avg.$661,850.28−9.4%
AGIO
Open-market sale10b5-1 plan03/0203/0318,055 sh3 trades$28.96avg.$522,872.8−9.9%
AGIO
Open-market sale10b5-1 plan25/12/3001/0218,703 sh2 trades$27.09avg.$506,664.27−11.6%
Open-market sale10b5-1 plan25/08/0825/08/1211,085 sh$36.67$406,486.95−8.2%
AGIO
Open-market sale10b5-1 plan25/06/2425/06/2618,700 sh2 trades$33.54avg.$627,198−14.3%
AGIO
Open-market sale10b5-1 plan25/03/0325/03/0412,947 sh2 trades$35.54avg.$460,136.38−12.3%
Open-market sale10b5-1 plan24/08/0824/08/1211,091 sh$42.75$474,140.25−12.3%
Open-market sale10b5-1 plan24/06/0524/06/0712,115 sh$48.84$591,696.6−15.3%
Open-market sale10b5-1 plan24/03/0524/03/054,156 sh$32.57$135,360.92−7.2%
Open-market sale10b5-1 plan24/01/2424/01/247,635 sh$21.64$165,221.4−13.4%
Open-market sale10b5-1 plan24/01/0924/01/0912,066 sh$22.99$277,397.34−23.2%
Open-market sale10b5-1 plan23/08/0823/08/1010,178 sh$25.48$259,335.44−27.7%
Open-market sale10b5-1 plan23/06/3023/06/3011,449 sh$28.36$324,693.64−44.8%